TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/06/2026
Voltar para busca
Dado oficial do USPTO
ONCOBETA WEBE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ONCOBETA WEBE
ST13
US500000079361563Classe
9, 35, 38, 42
Pedido
79361563
Registro
7554021
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 38, 42
Data de depósito
19/08/2022
Data de registro
05/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/11/2024
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
DE
Examinador
SWAIN, MICHELE LYNN
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
OncoBeta International GmbH
Representantes
Daniel P. Mullarkey Polsinelli PC
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 38Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable application software for the exchange of non-melanoma skin cancer data between patient or study patienttreating doctor; downloadable software for the exchange of non-melanoma skin cancer data between patient or study patienttreating doctor and storage of medicalclinical and patient information for use in the field of medical and clinical services; downloadable computer software for acquisition and analysis of patient health data for scientific and medical research purposes; downloadable application software for collection and acquisition of patient data relating to quality of lifetreatment comfort and cosmetic results after medical treatments; downloadable software in the form of a mobile application for use in electronic acquisition and transmission of medical information about patients; downloadable software for use in electronic acquisition and transmission of vital signs and non-vital signs of patients and related data in the field of medical treatment; downloadable electronic databases in the field of medicalclinical and patient data; downloadable electronic databases in the field of acquisition and provision of patient data relating to quality of lifetreatment comfort and cosmetic results after medical treatments
Classe 35
Database management; database management in the field of medical and clinical services and patient information; management and compilation of computerized databases in the field of medical and clinical services and patient information; collection and analysis of patient health data for business purposes; updating and maintenance of information in registries
Classe 38
Telecommunications servicesproviding access to computer databases in the field of medical and clinical services and patient information; providing access to telecommunications networks for provision of access to computer databases in the field of medical and clinical services and patient information; information and consultancy relating to telecommunications services for provision of access to computer databases in the field of medical and clinical services and patient information
Classe 42
Designdevelopment and maintenance of databases for medical and clinical services and patient information; designdevelopment and maintenance of computer software in the field of medical and clinical services and data storage; medical research concerning patient health data; medical and scientific research information in the field of oncology; designdevelopment and maintenance of databases for acquisition of patient data relating to quality of lifetreatment comfort and cosmetic results after medical treatments; scientific research concerning patient health data to doctorsmedical professionals and clinics in the field of oncology for scientific purposes; electronic storage of information relating to medicalclinical and patient information
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
25/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/06/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25/06/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
25/06/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/08/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/08/2024
PUBO
PUBLISHED FOR OPPOSITION
20/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/06/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
13/06/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
15/03/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/02/2024
GNFR
FINAL REFUSAL E-MAILED
10/02/2024
CNFR
FINAL REFUSAL WRITTEN
10/02/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
21/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/12/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/12/2023
RFNT
REFUSAL PROCESSED BY IB
07/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/07/2023
RFRR
REFUSAL PROCESSED BY MPU
19/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/06/2023
CNRT
NON-FINAL ACTION WRITTEN
13/06/2023
DOCK
ASSIGNED TO EXAMINER
07/06/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
23/05/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
28/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOBETA WEBE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.